NCT05206864已完成不适用
Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 试验地点
- 2
- 主要终点
- Safety as assessed by incidence of adverse advents
研究概览
简要总结
The aim of the trial is to determine if the synbiotic (prebiotic and probiotic), provided twice daily (capsule) is safe and tolerable in healthy adults.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Written informed consent
- •Stated availability throughout entire study period and willingness to fulfill all details of the protocol
- •Be in general good health as determined by a screening evaluation within 30 days of the first dose of SBD111 or placebo
- •Willing to comply with protocol and report on compliance and side effects during study period
- •Body Mass Index between 18.5 and 35 kg/m2
- •Normal cardiovascular parameters, systolic blood pressure ≤ 155 mm Hg, diastolic blood pressure ≤ 95 mm Hg)
排除标准
- •Are currently taking probiotic or prebiotic supplements, or have taken them in the past 30 days
- •Unwilling to avoid probiotics/prebiotics supplements for the duration of the study
- •Known or suspected allergies to probiotics
- •Received oral or parenteral antibiotics within 3 months of enrollment or prescribed antibiotics on day of enrollment.
- •Major surgery or endoscopy within last 3 months.
- •Subject is a smoker
- •Subject has a history of drug and/or alcohol abuse at the time of enrolment
- •Presence of any of the following:
- •Abnormal vital signs or clinically significant systems abnormalities based on screening questionnaire
- •Indwelling catheter or implanted hardware/prosthetic device or feeding tube
- •Febrile illness (oral temperature >37 degrees Celsius) or one or more episodes of diarrhea within 72 hours of baseline visit (first dose of study drug)
- •Active bowel leak, acute abdomen, colitis, or active GI disease or history of gastric or intestinal dysmotility, slowed transit time, variable small intestinal permeability, pancreatitis, or inflammatory bowel disease
- •History of Hepatitis B or Hepatitis C infections, cirrhosis, or chronic liver disease
- •Underlying structural heart disease or previous history of endocarditis or valve replacement
- •Immunosuppression including HIV positive, solid organ or stem cell transplant recipient, receiving any oral or parenteral immunosuppressive therapy, neutrophil count <500/mm^3, or an anticipated drop in the neutrophil count to <500/mm3
- •History of cancer excluding non-melanoma skin cancers or cancer more than 10 years ago
- •History of collagen vascular disease
- •Women only - pregnant, planning on becoming pregnant within the next 2 months, breastfeeding, positive urine pregnancy test during screening or within 24 hours of first dose of study drug.
- •Screening laboratory tests greater than upper normal limit (ULN) or less than lower normal limit (LLN):
- •WBCs < LLN or > ULN
- •Neutrophils < 1500/µl (1.5 x109/L)
- •Platelets < 100 x 10³/µl (100 x 109/L)
- •Haemoglobin < 9.0 g/dl (90 g/L)
- •f. GFR of > 40 mL/minute g. AST > 3 x upper limit of normal h. ALT > 3 x upper limit of normal i. Total Bilirubin > 1.5 x upper limit of normal
- •Any other condition that in the opinion of the investigator would jeopardize the safety or rights of the volunteer participating in the study or would make it unlikely the volunteer could complete the study.
结局指标
主要结局
Safety as assessed by incidence of adverse advents
时间窗: day-0 to day-28
Occurrence of adverse events defined as a Grade II-IV toxicity (FDA's Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Subjects Enrolled in Preventative Vaccine Clinical Trials, September 2007), that are possibly or probably related to administration of SBD111
次要结局
- Gastrointestinal Tolerability as assessed by Gastrointestinal Tolerability Questionnaire(day-0 to day-28)
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of OsteopeniaOsteopeniaNCT05009875Solarea Bio, Inc286
招募中
不适用
Efficacy and Safety of Probiotic Products for Digestive HealthHealthy AdultNCT06385639Wecare Probiotics Co., Ltd.60
已完成
不适用
Effect of Consuming a Combination of Probiotic Strains and a Combination of Plant Extracts and a Probiotic Strain on the Production and Nutritional Composition of Breast MilkBreast Milk ExpressionNCT04639232Biosearch S.A.58
Unknown
不适用
Effect of a Lactobacillus Strain on the Prevention of Recurrent Vaginal CandidiasisRecurrent Vulvovaginal CandidiasisNCT04639544Biosearch S.A.76
已完成
不适用
Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the ElderlySARS CoV-2 InfectionElderlyNCT04756466Biosearch S.A.201